December 31, 2024 - 00:43

OLD GREENWICH, Conn., December 30, 2024—Ellington Financial Inc. has disclosed its estimated book value per share of common stock, reporting a figure of $13.47 as of November 30, 2024. This announcement comes in the wake of the company's previously communicated monthly dividend of $0.13 per share, which was distributed to shareholders on December 26, 2024.
The dividend payment was made to those on record as of November 29, 2024, aligning with the same ex-dividend date. The estimated book value reflects the company's ongoing commitment to providing value to its shareholders while navigating the complexities of the financial landscape.
Investors and market analysts will likely scrutinize this estimate as it provides insight into the company's financial health and performance. As the year draws to a close, Ellington Financial continues to focus on strategic initiatives aimed at enhancing shareholder value and maintaining a robust financial position in the competitive market.
May 9, 2026 - 22:04
Compass Diversified Q1 Earnings Call HighlightsCompass Diversified, the publicly traded holding company known as CODI, reported its first-quarter 2026 earnings this week, with management framing the period as one of disciplined execution. Chief...
May 9, 2026 - 00:34
Urbana Corporation Has Filed 2026 First Quarter Interim Financial StatementsTORONTO - Urbana Corporation has submitted its unaudited interim financial statements and management discussion for the first quarter of 2026. The filing covers the three-month period ending March...
May 8, 2026 - 11:59
Australia regulator calls for urgent cybersecurity action to counter MythosAustralia`s corporate watchdog has called on the country`s financial industry to take urgent steps to address cybersecurity risks posed by advanced artificial intelligence systems, including a...
May 7, 2026 - 20:22
IN8bio Reports First Quarter 2026 Financial Results and Recent Business HighlightsIN8bio, a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, announced its financial results for the first quarter of 2026 along with key business updates. The...